← Back to home

LOCOREGIONALLY ADVANCED HEAD AND NECK SQUAMOUS CELL CARCINOMA (LA-HNSCC)

Clinical trials for LOCOREGIONALLY ADVANCED HEAD AND NECK SQUAMOUS CELL CARCINOMA (LA-HNSCC) explained in plain language.

Never miss a new study

Get alerted when new LOCOREGIONALLY ADVANCED HEAD AND NECK SQUAMOUS CELL CARCINOMA (LA-HNSCC) trials appear

Sign up with your email to follow new studies for LOCOREGIONALLY ADVANCED HEAD AND NECK SQUAMOUS CELL CARCINOMA (LA-HNSCC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug aims to hunt down lingering cancer after treatment

Disease control Recruiting now

This study is testing an investigational drug called AZD2936 to see if it can clear tiny traces of leftover cancer and prevent the disease from returning. It is for patients with high-risk, locally advanced head and neck cancer who have already finished their main treatment (like…

Matched conditions: LOCOREGIONALLY ADVANCED HEAD AND NECK SQUAMOUS CELL CARCINOMA (LA-HNSCC)

Phase: PHASE2 • Sponsor: University Health Network, Toronto • Aim: Disease control

Last updated Mar 30, 2026 14:27 UTC

LOCOREGIONALLY ADVANCED HEAD AND NECK SQUAMOUS CELL CARCINOMA (LA-HNSCC)

Get alerted when new LOCOREGIONALLY ADVANCED HEAD AND NECK SQUAMOUS CELL CARCINOMA (LA-HNSCC) trials appear

New drug aims to hunt down lingering cancer after treatment